Electronic unit for drug delivery device and mobile electronic device - Patents.com
The integration of an electronic circuit with drug delivery devices for proximity-based authorization and localization addresses user safety and ease of use challenges, enhancing security and usability through wireless communication with mobile devices.
Patent Information
- Application Number
- JP2024526551
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-03
- Filing Date
- 2022-11-01
- Publication Date
- 2024-11-19
AI Technical Summary
Existing drug delivery devices face challenges in ensuring user safety and ease of use, particularly for individuals with chronic diseases or visual impairments, and require improvements in localization and authorization to prevent unauthorized use.
The integration of an electronic circuit with a drug delivery device that utilizes wireless communication with mobile electronic devices to determine distance and relative position, enabling or disabling device functions based on proximity, and incorporating UWB-based proximity sensors for precise positioning and authorization.
Enhances user safety and ease of use by ensuring authorized access and aiding in device localization, while preventing unauthorized use through proximity-based authorization and precise positioning.
Smart Images

Figure 2024543031000001_ABST
Abstract
Description
[Technical field]
[0001] The present disclosure relates to electronic circuits or units for drug delivery devices, drug delivery devices, auxiliary devices for drug delivery devices, methods for controlling electronically implemented functions of a drug delivery device or associated with a drug delivery device, and computer programs for device control and / or user authentication. [Background technology]
[0002] Drug delivery devices for setting and dispensing single or multiple doses of liquid medication are per se well known in the art. Typically, such devices have a purpose substantially similar to a common syringe.
[0003] Drug delivery devices, such as injection devices and needle-based injection system (NIS) devices, such as pen-type injectors, must meet several user-specific requirements. For example, if a patient suffers from a chronic disease such as diabetes, the patient may be physically frail and may also suffer from visual impairment. Therefore, a suitable drug delivery device, especially for home medicine, needs to be robust in structure and should be easy to use. Furthermore, the operation and general handling of the device and its components should be straightforward and easily understandable. Such an injection device should provide for the setting and subsequent dispensing of doses of a drug of variable size. Furthermore, the dose setting as well as the dose dispensing procedure should be easy to operate and clear.
[0004] Patients with certain diseases may require specific amounts of medication to be injected via a syringe pen or infused via a pump.
[0005] Some drug delivery or injection devices offer variable size dose selection and injection of a pre-set dose of medication, while other injection devices offer fixed dose setting and dosing, where the amount of medication to be injected according to a given prescription schedule is always the same and does not or cannot be changed over time.
[0006] Needle-based injections performed by various injection devices are increasingly associated with measuring and logging data regarding the amount of medication set or dispensed or injected at a particular date or time. To this end, injection devices may include electronic circuitry that provides data acquisition and / or data logging and communication of collected or measured medication-related data.
[0007] Such an electronic circuit or electronic unit may be implemented or integrated in the injection device itself. Alternatively, such an electronic circuit or electronic unit may be provided by an auxiliary or add-on device configured to be releasably attached to the injection device and operable to log injection-related data during use of the injection device. Furthermore, the electronic circuit for data logging may also comprise a communication interface for transmitting previously stored injection-related data to an external electronic device for further data processing.
[0008] Some users or patients may need to administer different medications by using different drug delivery devices, which may appear similar at first glance. Also, the devices may be stored in the home, theoretically allowing multiple people to access the devices instead of just one. Additionally, some patients may have difficulty locating, finding, or retrieving drug delivery devices within their homes. Summary of the Invention [Problem to be solved by the invention]
[0009] It is therefore desirable to provide improvements to electronic circuitry for drug delivery devices that enable and provide a secure, intuitive and smooth support for a user to use the drug delivery device. It is further desirable to provide computer programs and respective hardware components to promote patient safety so as to prevent unauthorized use of the drug delivery device by users who are not authorized to use the drug delivery device. Furthermore, an objective is to enable or simplify locating the drug delivery device when it is missing. [Means for solving the problem]
[0010] In one aspect, the present disclosure relates to an electronic circuit for a drug delivery device. The drug delivery device is operable to dispense a medication, e.g., a liquid medication, by injection. The electronic circuit includes a communication interface operable to wirelessly communicate with a mobile electronic device and to transmit at least a wireless signal to the mobile electronic device. The wireless signal allows for determining and / or quantitatively measuring at least one of a distance and a relative position between the electronic circuit and the mobile electronic device. The electronic circuit further includes a processor operably connected to the communication interface. The processor is operable to enable, disable, trigger, or terminate execution of an electronically implemented function of the electronic circuit based on an analysis of at least one of the distance and the relative position.
[0011] Typically, the processor is operable to grant or not grant access to an electronically implemented function of the electronic circuit. When the processor grants access to an electronically implemented function, the processor is operable to enable, disable, trigger or terminate execution of the respective function. When the processor does not grant access to an electronically implemented function, for example when a distance or relative position is determined based on a radio signal outside a predetermined range, the processor is not operable to enable, disable, trigger or terminate execution of the electronically implemented function of the electronic circuit.
[0012] The electronic circuitry is operable to communicate with the mobile electronic device, and in particular with a counter communication interface of the mobile electronic device, to quantitatively measure or determine at least one of the distances between the electronic circuitry and the mobile electronic device. Additionally or alternatively, the wireless communication with the electronic circuitry and the mobile electronic device serves to determine and / or measure the relative positions of the electronic circuitry and the mobile electronic device.
[0013] The relative position between the electronic circuit and the mobile electronic device can indicate the distance as well as the direction between these objects. For example, from the perspective of the mobile electronic device, the relative position indicates the direction and distance where the electronic circuit is actually located relative to the mobile electronic device. The relative position can be characterized by a distance and a distance vector that indicates the relative angle or direction of the shortest distance between the electronic circuit and the mobile electronic device.
[0014] By determining at least one of a distance and a relative position between the electronic circuit and the mobile electronic device, a particular function of the electronic circuit is enabled, disabled, e.g., triggered or terminated, by using the distance and / or the relative position as a control parameter.
[0015] In a typical implementation, when the distance is below a predetermined acceptance distance, access is provided to the electronically implemented functionality of the electronic circuit. As long as the distance is above the predetermined acceptance distance, the processor can be configured to not accept access to the electronically implemented functionality of the electronic circuit. Similarly, the distance as well as the distance vector and / or the orientation of the electronic circuit relative to the mobile electronic device can be used as control parameters.
[0016] In effect, by measuring at least one of distance and relative position and using this parameter as a control parameter to provide access to the electronically implemented functionality of the electronic circuit, the mobile electronic device, and in particular wireless communication with the mobile electronic device, can provide, for example, a key lock to unlock or authorize the electronically implemented functionality of the electronic circuit.
[0017] According to another example, one of the processor, the wireless communication interface, and the mobile electronic device is configured to measure and / or determine at least one of a distance and a relative position between the electronic circuit and the mobile electronic device. In some examples, one of the communication interface and the processor of the electronic circuit is operable to derive and / or measure and / or determine at least one of a distance and a relative position between the electronic circuit and the mobile electronic device, for example, by processing wireless communication signals obtained or received by the communication interface.
[0018] In another example, the mobile electronic device is configured to determine, derive, or calculate a distance and / or a relative position between the electronic circuit and the mobile electronic device. Here, the distance and / or the relative position determined or calculated by the mobile electronic device can be transmitted to the electronic circuit through a wireless communication link established between the opposing communication interface of the mobile electronic device and the communication interface of the electronic circuit. Here, the electronic circuit can be inoperative to derive or calculate the distance and / or the relative position between the electronic circuit and the mobile electronic device. Conversely, the respective information about at least one of the distance and the relative position can be derived by the mobile electronic device and thus transmitted to the communication interface of the electronic circuit through the wireless communication link.
[0019] The respective distance or relative position information is then made available to the electronic circuitry, where the computing power for calculating at least one of the distance and relative position can be provided exclusively by the mobile electronic device, e.g., implemented as a smartphone, a smartwatch, a fitness tracker, e.g., one of the wearable electronic devices.
[0020] According to a further example, the processor of the electronic circuit is operable to analyze at least one of the distance and the relative position, where at least one of the distance and the relative position can be derived or calculated by the processor. Alternatively, the distance and / or the relative position can be obtained by the mobile electronic device via wireless communication.
[0021] In some examples, the communication interface of the electronic circuit is implemented as a transceiver operable to transmit and receive wireless signals to and from the opposing communication interface of the mobile electronic device. In some examples, the mobile electronic device may initially transmit or broadcast a wireless signal to be received by the communication interface of the electronic circuit. Here, the communication interface of the electronic circuit may be configured to process the wireless signal received from the opposing communication interface and may be further configured to generate a response wireless signal as well as transmit such a response wireless signal to the opposing communication interface. Thus, the communication interface of the electronic circuit may be implemented to provide bidirectional wireless communication with the opposing communication interface of the mobile electronic device.
[0022] In some examples, the communication interface is operable to modify a wireless signal received from the opposing communication interface of the mobile electronic device and to transmit or transmit a correspondingly modified wireless signal back to the opposing communication interface. The opposing communication interface and optional processor of the mobile electronic device may then be operable to derive or calculate at least one of a distance and a relative position from a response signal of the communication interface of the electronic circuit.
[0023] In some examples, the communication interface of the electronic circuit can initiate transmission of wireless signals and receive return wireless signals from at least one mobile electronic device, where the opposing communication interface of the mobile electronic device can be configured to receive, process, and / or modify the wireless signals initiated and / or transmitted by the communication interface of the electronic circuit. In any case, the communication interface of the electronic circuit as well as the opposing communication interface of the mobile electronic device are implemented as transceivers operable to transmit and receive wireless signals.
[0024] According to a further example, the electronic circuit includes a proximity sensor operable to measure at least one of a distance and a relative position between the electronic circuit and at least one of the mobile electronic devices. The proximity sensor may be implemented by wireless communication between a communication interface of the electronic circuit and a counter communication interface of the at least one mobile electronic device. The proximity sensor may be implemented within the communication interface. In other examples, the communication interface constitutes or forms the proximity sensor.
[0025] In effect, by measuring at least one of a distance and a relative position between an electronic circuit integrated or attached to the drug delivery device and the at least one mobile electronic device, a respective electronically implemented function of the electronic circuit and / or the drug delivery device can be performed or executed in response to one of a distance and a relative position between the electronic circuit and the at least one mobile electronic device. In this manner, it can be substantially ensured that an electronically implemented device function is only and / or exclusively enabled, disabled, triggered, or terminated when the mobile electronic device is within a particular geometrical region or orientation relative to the electronic circuit.
[0026] According to a further example, the proximity sensor is operatively connected to a processor, where the processor may be operable to evaluate the at least one identification signal only when a distance between the electronic circuitry and the at least one mobile electronic device is within a predetermined operating distance and / or when the electronic circuitry is within a predetermined relative operating position with respect to the at least one mobile electronic device.
[0027] Proximity sensors can provide a more automated unlocking of certain functions of the drug delivery device. In some examples, if the drug delivery device is equipped with an electromechanical interlock controllable by an electronic implementation of an electronic circuit, the proximity of the mobile electronic device to the electronic circuit and thus to its proximity sensor can trigger the release or deactivation of the interlock when an identification signal transmitted from the mobile electronic device matches a user-specific data record.
[0028] According to a further example, at least one of the communication interface and the proximity sensor is implemented as a UWB (ultra-wideband) based proximity sensor configured to quantitatively measure at least one of a distance and a relative position between the electronic circuitry and the at least one mobile electronic device based on transmission and reception of electromagnetic ultra-wideband signals.
[0029] Typically, electromagnetic UWB signals include very short RF pulses that cover a relatively large portion of the radio spectrum at relatively low energy levels. A UWB-based communication link between a proximity sensor and at least one mobile electronic device allows the distance between the electronic circuit and the mobile electronic device to be determined with high accuracy, for example within a few centimeters or less.
[0030] UWB-based communication between the proximity sensor, and thus the electronic circuitry, and the at least one mobile electronic device may also provide relative position information indicating the relative position and / or orientation of the electronic circuitry with respect to the at least one mobile electronic device, and vice versa.
[0031] UWB-based wireless communication makes it possible not only to obtain the distance of an object, but also to measure or determine the direction in which an object is actually located or positioned relative to another object. UWB-based communication between a proximity sensor and at least one mobile electronic device is particularly useful for implementing, for example, a pager function for the mobile electronic device, thus making it possible to discover electronic circuits attached to or integrated in a drug delivery device.
[0032] In a further example of the electronic circuit, the processor is operable to generate a control command based on an analysis of at least one of a distance and a relative position between the electronic circuit and the mobile electronic device. - generating a warning or signal perceptible to a user by means of a signal unit; - Locking or unlocking a drive mechanism of a drug delivery device by means of an electromechanical interlock; - triggering or terminating the transmission of data by the communication interface; - configured to cause at least one of switching the electronic circuit from a standby mode to an active mode, or vice versa, switching the electronic circuit from an active mode to a standby mode.
[0033] In some examples, the processor generates a control command to cause the signal unit to generate one of the approval or confirmation signals, for example when the distance between the electronic circuit and the mobile electronic device is within a predetermined approved or approved distance, respectively. The user-perceptible signal or alert may indicate to the user, for example, that functionality of the electronic circuit and / or drug delivery device is now enabled or unlocked.
[0034] In other situations, for example when the distance exceeds an approved distance, the processor may be operable to generate a control command to cause the signal unit to generate a user-perceivable warning or signal indicating locking of the electronic circuitry and / or respective electronically implemented functions of the drug delivery device. In some examples, the drive mechanism of the drug delivery device may be mechanically locked or blocked as long as the distance between the mobile electronic device and the electronic circuitry exceeds a predefined approved distance. Additionally or simultaneously, the signal unit may be operable to generate a respective indication to the user.
[0035] According to a further example, the communication interface of the electronic circuit is configured to exchange user specific data with the mobile electronic device. The user specific data may include: - Drug type, - time and / or date of the medication administration action, - the amount of medication administered; - Including at least one of the user's exercise data.
[0036] The wireless communication link established between the communication interface of the electronic circuit and the opposing communication interface of the mobile electronic device is not only operable to exchange wireless signals for measuring or determining at least one of distance and relative position, but can also be used to exchange user-specific data or further data specific for the configuration of the drug delivery device. To that extent, the wireless communication link between the electronic circuit and the mobile electronic device serves two or more purposes, namely the functionality for measuring distance and the transmission of user-specific and / or device-specific information.
[0037] In some examples, the electronic circuitry is implemented in an electronic unit of the drug delivery device. The drug delivery device can be implemented as an injection device, for example as a pen-type injector. In other examples, the electronic circuitry is part of or integrated into an auxiliary device configured for attachment or fastening and / or fixing to a housing of the injection device.
[0038] According to another aspect, the present disclosure further relates to a drug delivery device operable to dispense a medicament, for example operable to dispense the medicament by injection. The drug delivery device includes a housing for receiving a medicament container filled with the medicament. Typically, the medicament container includes a cartridge filled with a liquid medicament configured for injection into a patient's body tissue. The drug delivery device further includes a drive mechanism operably connectable to the medicament container for expelling or drawing a dose of the medicament from the medicament container. The drug delivery device further includes an electronic circuit as described above integrated in the housing and / or operably connected to the drive mechanism.
[0039] When implemented in or on the drug delivery device, the electronic circuitry may also be operable to monitor operation of the drug delivery device. The electronic circuitry may be operable to measure and / or record setting and / or dispensing of a dose of medication initiated or performed by a user of the drug delivery device.
[0040] Because the drug delivery device includes the electronic circuitry described above, all of the features, effects, and benefits described above in relation to the electronic circuitry for the drug delivery device apply equally to the drug delivery device, and vice versa.
[0041] According to another aspect, the present disclosure relates to an auxiliary or add-on device for the drug delivery device described above. The auxiliary device includes a housing and a fastener for fastening and / or securing the auxiliary device to the housing of the drug delivery device. Furthermore, the auxiliary device includes the electronic circuit described above. To that extent, all configurations, effects, and benefits described above in relation to the electronic circuit apply equally to the auxiliary device and vice versa.
[0042] The auxiliary device, when attached to the drug delivery device, may be further operable to measure or determine a configuration of the drug delivery device. The auxiliary device may be particularly configured to measure the size of a dose currently set or dispensed by the injection device. Typically, the auxiliary device is operable and / or configured to monitor repeated or frequent use of the drug delivery device.
[0043] The auxiliary device may be configured to generate and / or store and communicate a dosing or injection history performed by the injection device. Typically, the auxiliary device is operable to store and / or monitor the date and time that an amount of medication was dispensed or injected by the drug delivery device. Specific amounts of medication, such as fixed or variable size doses, may be determined, measured, and / or recorded as well.
[0044] In another aspect, the present disclosure relates to a mobile electronic device for use with a drug delivery device. The mobile electronic device includes a mobile communication interface operable to wirelessly communicate with a mobile or counter communication interface of an electronic circuit associated with the drug delivery device. The mobile communication interface is typically operable to transmit at least a wireless signal to the communication interface. The wireless signal allows for determining at least one of a distance and a relative position between the electronic circuit and the mobile electronic device.
[0045] The mobile electronic device further includes a processor operatively connected to the mobile communication interface, the processor operable to enable, disable, trigger, or terminate execution of an electronically implemented function of the mobile electronic device based on an analysis of at least one of the distance and the relative position.
[0046] Here, simultaneously with the electronic circuit or drug delivery device described above, a processor of the mobile electronic device is operable to process at least one of the distance and relative position between the electronic circuit and the mobile electronic device to provide or deny, and thus authorize or not, access to electronically implemented functions of the mobile electronic device.
[0047] Thus, certain functions of the mobile electronic device, such as the ability of the mobile electronic device to cooperate with a drug delivery device, may be disabled so long as the distance and / or relative position between the mobile electronic device and the electronic circuitry exceeds or is outside of a predetermined approval range, distance, or position.
[0048] In some examples, the electronically implemented functionality of the mobile electronic device includes reading device-specific or drug-specific or user-specific data of an electronic circuit associated with the drug delivery device, and thus reading the data and / or establishing the respective data-carrying communication link requires the distance between the mobile electronic device and the electronic circuit to be within a predetermined approved distance.
[0049] In some examples, when the mobile electronic device can be implemented as a remote control or remote controller for a drug delivery device, it may be necessary to reduce the distance between the drug delivery device associated with or comprising the electronic circuitry and the mobile electronic device to be within an approved distance. As long as the mobile electronic device is located outside of a predetermined approved distance or approved location, the remote control functionality of the mobile electronic device can be disabled. When the distance between the mobile electronic device and the electronic circuitry is within a predetermined approved distance and / or the relative location of the mobile electronic device with respect to the electronic circuitry is within a predetermined approved relative location range, the respective functionality of the mobile electronic device can be enabled.
[0050] Thus, a type of remote control for a mobile electronic device and / or certain drug delivery device related functions of the mobile electronic device may require close proximity of the mobile electronic device to the drug delivery device, which requirement may enhance patient safety and compliance with the intended use of the drug delivery device.
[0051] According to another example, the mobile electronic device includes a proximity sensor operably connected to the processor and operable to measure at least one of a distance and a relative position between the electronic circuit and the mobile electronic device. The proximity sensor can be integrated into the mobile communication interface. In some examples, the mobile communication interface provides or contributes to the proximity sensor.
[0052] The mobile communication interface may provide or correspond to a counter communication interface as described above in relation to the mobile electronic device. The mobile communication interface is thus operable and configured to wirelessly transmit electromagnetic signals to the communication interface of the electronic circuit. The mobile communication interface is also configured to receive, e.g. in return, a respective wireless signal, e.g. a response signal, from the communication interface of the electronic circuit.
[0053] According to a further example, at least one of the mobile communication interface and the proximity sensor includes a UWB antenna operable to transmit and / or receive ultra-wideband signals, the UWB antenna typically being integrated into one of the proximity sensor and the communication interface described above.
[0054] According to another example, the mobile electronic device: - the distance between the electronic circuit and the mobile electronic device, and - further comprising a signal unit operable to indicate and / or represent to a user at least one of the relative positions of the electronic circuitry with respect to the position of the mobile electronic device.
[0055] The signal unit may include a one-dimensional or two-dimensional display configured to visually represent at least one of the distance and the relative position. In other examples, the signal unit may simply include a light source operable to generate and provide a visible light signal. The signal unit may be operable to provide light signals of different colors, different brightness, and / or different durations. Thus, at least one of the distance and the relative position between the electronic circuit and the mobile electronic device may be indicated by the light source, for example, by varying at least one, some, or all of the frequency, brightness, and duration of the blinking light, by varying the intensity of the light signal, and / or by varying the color of the light signal.
[0056] In other examples, the signal unit includes a speaker or similar hardware component for generating an acoustic signal, and wherein the strength or intensity as well as the duration and frequency of the acoustic signal can be configured to indicate at least one of a distance and a relative position.
[0057] In other examples, the signal unit is operable to generate a haptically perceptible signal, for example by generating a mechanical vibration or by generating a mechanically or haptically perceptible knocking signal, and wherein by varying at least one of an intensity, duration, and frequency of the haptic signal, the signal unit can indicate at least one of a distance and a relative position between the electronic circuitry and the mobile electronic device.
[0058] According to further examples, the mobile electronic device is implemented as an external electronic device and is separate from the electronic circuitry of the drug delivery device or separate from the electronic circuitry of an auxiliary device that is attachable and / or fixable to the drug delivery device. In some examples, the mobile electronic device is a wearable electronic device. In some examples, the mobile electronic device is implemented as a smartphone, a tablet computer, a smart watch, a fitness tracker, or a wireless tag.
[0059] Typically, the mobile electronic device is implemented as a mobile electronic device for communicating with the electronic circuitry described above, and to that extent, all configurations, effects, and benefits described above in relation to the electronic circuitry, drug delivery device, and / or auxiliary device may equally or simultaneously apply to the mobile electronic device, and vice versa.
[0060] According to another aspect, the present disclosure also relates to a method of controlling an electronically implemented function associated with a drug delivery device, such as the drug delivery device described above. The method includes establishing a wireless communication link between an electronic circuit attached to or integrated with the drug delivery device and a mobile electronic device. The method further includes determining at least one of a distance and a relative position between the electronic circuit and the mobile electronic device by transmission of wireless signals between the electronic circuit and the mobile electronic device. The method further includes analyzing or evaluating the at least one of the distance and the relative position. Furthermore, the method includes at least one of enabling, disabling, triggering, or terminating execution of at least one of the electronically implemented functions of the electronic circuit and the mobile electronic device based on the analysis or evaluation of the at least one of the distance and the relative position.
[0061] Typically, the method can be implemented by at least one or some of the above-mentioned electronic circuitry, the above-mentioned drug delivery device, the above-mentioned auxiliary device, and the above-mentioned mobile electronic device. In some examples, the method is performed or executed by wireless communication between the above-mentioned mobile electronic device and the electronic circuitry, typically implemented in one of the drug delivery device and the auxiliary device.
[0062] In some examples of this method, at least one of enabling, disabling, triggering, or terminating execution of at least one electronically implemented function of the electronic circuit and the mobile electronic device includes: - generating a warning or signal perceptible to a user by means of a signal unit; - Locking or unlocking a drive mechanism of a drug delivery device by means of an electromechanical interlock; - triggering or terminating the transmission of data by the communication interface; - switching the electronic circuitry from a standby mode to an active mode, or vice versa, including at least one or more of:
[0063] In some examples, the method may also be implemented by a first electronic circuit implemented in the drug delivery device, a second electronic circuit implemented in the auxiliary device, and the mobile electronic device described above, where the first and second electronic circuits each include the electronic circuit described above.
[0064] According to another aspect, the present disclosure relates to a computer program comprising computer readable instructions which, when executed by at least one processor of the electronic circuitry described above or by at least one processor of the mobile electronic device described above, cause the respective processor to establish a wireless communication link between an electronic circuitry attached to or integrated in the drug delivery device and a user's mobile electronic device.
[0065] The computer readable instructions may further cause the processor to determine at least one of a distance and a relative position between the electronic circuit and the mobile electronic device by transmission of wireless signals between the electronic circuit and the mobile electronic device. The computer readable instructions may also trigger transmission and reception of the respective wireless electromagnetic signals. The computer readable instructions may further cause the processor to analyze or evaluate the at least one of the distance and the relative position, and be operable to enable, disable, trigger, or terminate execution of an electronically implemented function of at least one of the electronic circuit and the mobile electronic device based on the analysis or evaluation of the at least one of the distance and the relative position.
[0066] Typically, the computer program is configured to execute the above-mentioned method of controlling electronically implemented functionality of a drug delivery device or electronically implemented functionality associated with a drug delivery device. To that extent, all configurations, effects and benefits described above in relation to electronic circuits for a drug delivery device, a drug delivery device operable to dispense a medicament, an auxiliary device for such a drug delivery device, a mobile electronic device for use with a drug delivery device, and / or a method of controlling electronically implemented functionality apply equally to the computer program, and vice versa.
[0067] According to a further aspect, the present disclosure provides a method for producing a method for a method of manufacturing a semiconductor device, comprising: - a drug delivery device comprising an electronic circuit as described above, - an auxiliary device attachable to the drug delivery device and comprising the electronic circuitry described above; and - to a set including one, any selected plurality, or all of the mobile electronic devices mentioned above, to the extent that all features, effects, and benefits mentioned above in relation to any one of the electronic circuit, the drug delivery device, the auxiliary device, and the mobile electronic device apply equally to this set, and vice versa.
[0068] Generally, the scope of the present disclosure is defined by the contents of the claims. The injection device is not limited to a particular embodiment or example, but includes any combination of elements of different embodiments or examples. To that extent, the present disclosure encompasses any combination of the claims and any technically feasible combination of the disclosed features in relation to the different examples or embodiments.
[0069] According to a further example, at least one wireless signal transmitted between the electronic circuitry and the mobile electronic device includes acquired athletic data of a user of the mobile electronic device. The processor and / or the mobile electronic device are further operable to evaluate the acquired athletic data by comparing the acquired athletic data with stored athletic data of a user-specific data record. The user-specific data record can be provided within a storage of one of the electronic circuitry and the mobile electronic device.
[0070] According to a further example, the processor of the electronic circuit and / or the processor of the mobile electronic device can be operable to generate a data consistency index indicative of a degree of consistency between the acquired athletic data and / or the stored athletic data. The processor can be further operable to enable, disable, trigger or terminate execution of an electronically implemented function of the electronic circuit based on the data consistency index. In this way, users authorized to use the drug delivery device can be identified by the athletic data.
[0071] The athletic data can be acquired or collected by electronic circuitry or, for example, by a mobile electronic device carried by or attached to the user. Typically, the athletic data of a user is acquired over a predetermined period of time, and / or the athletic data is acquired at a specific and predetermined time point or on a specific day. The athletic data can be characteristic and distinct for each user who uses the drug delivery device and / or the mobile electronic device. The athletic data can provide a kind of fingerprint for each user.
[0072] Typically, a first user is characterized by the athletic data of a first user-specific data record. Correspondingly, a second user can be characterized by the athletic data of a second user-specific data record. By comparing athletic data acquired while the user is moving or while the user is performing or enacting a particular movement or athletic pattern, and comparing the acquired athletic data of this user with the athletic data of the user-specific data record, a user of the mobile electronic device can be identified.
[0073] Typically, in some instances, a user-specific data record is assigned or mapped to a particular drug delivery device. When the same user uses the drug delivery device and athletic data for this particular user is acquired, the acquired athletic data shows a high degree of match or similarity when compared to the user-specific data record assigned or mapped to the drug delivery device. Accordingly, the respective user is authorized to use the drug delivery device.
[0074] In response, at least one function of the electronic circuit, and therefore the drug delivery device, is enabled, disabled, triggered, or terminated in response to a request by the user of the drug delivery device. In another situation, when a second user who is not authorized to use the drug delivery device attempts to use this particular device, the motion data of this second user is collected or acquired and compared with the motion data of the user-specific data record of the first user mapped to this particular drug delivery device. Because the motion data of the second user is differentiated from the motion data of the user-specific data record, the degree of match or similarity determined between the acquired motion data of the second user and the stored motion data of the user-specific data record of the first user is significantly lower. In response, the respective function of the drug delivery device is enabled, disabled, triggered, or terminated based on the data match index.
[0075] In some examples, the respective device functions may be enabled or triggered when the user is authorized to use the drug delivery device, while in other situations, the respective functions of the drug delivery device may be disabled or terminated when an analysis or evaluation of the user's athletic data reveals that the user is not authorized to use the drug delivery device, for example, based on a low degree of match between the acquired athletic data and the stored athletic data.
[0076] According to a further example, the user's motion data is acquired by a sensor. Thus, the electronic circuit and / or the mobile electronic device includes a sensor operably connected to the processor. The sensor can be operable to recognize the user's motion or motion pattern and / or gesture when the user moves or when at least one of the mobile electronic device and the drug delivery device moves. Thus, the user's motion profile or pattern can be detected and / or quantitatively measured as such gesture or typical gesture of the user. Such motion pattern or gesture can be permanently or optionally acquired and compared with the motion or motion pattern and / or gesture data of the user-specific data record.
[0077] Typically, the sensor includes at least one of an acceleration sensor, a rotation sensor, a position sensor, and a distance sensor. The sensor is operable to generate an electrical sensor signal. The processor is typically operable to evaluate and / or analyze the sensor signal to derive and / or characterize motion data indicative of a characteristic motion or gesture of a user when moving the electronic circuit and / or the mobile electronic device, and thus the sensor.
[0078] Deviations of the acquired motion data from the stored motion data can be detected, thus resulting in a significantly lower degree of match and generating a significantly lower match index. Depending on the size of the match index, execution of functions of the electronic circuitry and / or associated drug delivery device, which typically require respective authorization, can be enabled, disabled, triggered or terminated.
[0079] When the sensor constitutes a position sensor, the sensor may be operable to determine an absolute or relative position, for example by communicating with a satellite-based positioning system or by communicating with another electronic device, such that the absolute position of the sensor, for example in the form of geographic coordinates or for example in the form of relative coordinates, relative to another electronic device may be measured or determined.
[0080] In a further example, the electronic circuitry may also include a clock that may map motion or position data acquired by the sensor to dates, times, and / or time intervals, thereby generating a motion or movement profile over time that is indicative of a user's typical motion patterns.
[0081] As an example, users can be identified as being in a particular geographic location at a typical point in time or time interval. For example, a first user can be characterized by being in a particular office building for 8 hours a day, e.g., from 9:00 to 17:00. The user may leave the office building at a fixed time for a lunch break, e.g., for a 30 minute time interval.
[0082] Furthermore, the user can be recognized by, for example, traveling from home to work by car or public transport at a particular time. Such motion data may be captured and acquired over a relatively long time interval. When the currently acquired motion data significantly deviates from the long-term average of the respective motion data, this may indicate a situation where a different user is using the respective electronic circuit.
[0083] The deviation of the acquired motion data from the stored or average motion data can be quantitatively expressed by a data consistency index, thus generating a probability or likelihood that the currently acquired motion data was obtained from the particular user that has been mapped or assigned to the user-specific data record, and the distance thereto.
[0084] According to a further example, at least a portion of the user's exercise data is acquired by the communication interface via wireless communication with at least one of a satellite positioning system, an access point of a communication network, an auxiliary device attachable to the drug delivery device, an electronic unit or electronic circuit of the drug delivery device, or a counterpart communication interface of a mobile electronic device such as a mobile electronic device.
[0085] Thus, a high degree of flexibility is provided with respect to the method of acquiring the user's motion data. To that extent, even electronic devices that do not include sensors such as acceleration sensors, rotation sensors, position sensors, and distance sensors can acquire the user's motion data. For example, in urban areas, a large number of access points of a communication network can be provided, and when the electronic circuit undergoes a movement or motion, the communication interface of the electronic circuit establishes a communication link to such an access point. By simply establishing a log of communication links with different access points of the communication network during a movement or motion from one place to another, a motion pattern or motion profile can be generated that can indicate the user's habitual movement or motion.
[0086] In this context, the term "distal" or "distal end" refers to the end of the injection device that faces towards the injection site of a person or animal, whereas the term "proximal" or "proximal end" refers to the opposite end of the injection device that is furthest away from the injection site of a person or animal.
[0087] The terms "drug" or "medicament" are used interchangeably herein to describe a pharmaceutical formulation containing one or more active pharmaceutical ingredients or their pharma- ceutically acceptable salts or solvates, and optionally a pharma- ceutically acceptable carrier. An active pharmaceutical ingredient ("API"), in its broadest sense, is a chemical structure that has a biological effect on humans or animals. In pharmacology, drugs or medicines are used to treat, cure, prevent, or diagnose diseases or otherwise improve physical or mental well-being. Drugs or medicines can be used for a limited duration or periodically for chronic disorders.
[0088] As described below, drugs or agents may include at least one API or combinations thereof in various types of formulations for the treatment of one or more diseases. Examples of APIs may include small molecules with molecular weights of 500 Da or less, polypeptides, peptides, and proteins (e.g., hormones, growth factors, antibodies, antibody fragments, and enzymes), carbohydrates and polysaccharides, as well as nucleic acids, double-stranded or single-stranded DNA (including naked and cDNA), RNA, antisense nucleic acids such as antisense DNA and RNA, small interfering RNA (siRNA), ribozymes, genes, and oligonucleotides. Nucleic acids may be incorporated into molecular delivery systems such as vectors, plasmids, or liposomes. Mixtures of one or more drugs are also contemplated.
[0089] The drug or agent can be contained in a primary package or "drug container" adapted for use in a drug delivery device. The drug container can be, for example, a cartridge, syringe, reservoir, or other rigid or flexible vessel configured to provide a chamber suitable for storage (e.g., short-term or long-term storage) of one or more drugs. For example, in some cases, the chamber can be designed to store the drug for at least one day (e.g., from one day to at least 30 days). In some cases, the chamber can be designed to store the drug for about one month to about two years. Storage can be at room temperature (e.g., about 20° C.) or at refrigerated temperatures (e.g., from about −4° C. to about 4° C.). In some cases, the drug container can be or include a dual-chamber cartridge configured to separately store two or more components of a pharmaceutical formulation to be administered (e.g., an API and a diluent, or two different drugs), one in each chamber. In such cases, the two chambers of the dual-chamber cartridge can be configured to allow mixing between two or more components prior to and / or during administration to the human or animal body. For example, the two chambers can be configured to be in fluid communication with each other (e.g., via a conduit between the two chambers) and to allow mixing of the two components by a user, if desired, prior to administration. Alternatively or additionally, the two chambers can be configured to allow mixing upon administration of the components to the human or animal body.
[0090] The drugs or agents contained in the drug delivery devices described herein can be used for the treatment and / or prevention of many different types of medical disorders. Examples of disorders include, for example, diabetes or complications associated with diabetes, such as diabetic retinopathy, thromboembolic disorders, such as deep vein thromboembolism or pulmonary thromboembolism. Further examples of disorders are acute coronary syndromes (ACS), angina, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis and / or rheumatoid arthritis. Examples of APIs and drugs are those found in handbooks such as Rote Liste 2014 (e.g., but not limited to, main groups 12 (antidiabetic agents) or 86 (oncology agents)) and the Merck Index, 15th edition.
[0091] Examples of APIs for the treatment and / or prevention of type 1 or type 2 diabetes or complications associated with type 1 or type 2 diabetes include insulin, e.g., human insulin, or a human insulin analog or derivative, glucagon-like peptide (GLP-1), a GLP-1 analog or GLP-1 receptor agonist, analog or derivative thereof, a dipeptidyl peptidase-4 (DPP4) inhibitor, or a pharma-ceutically acceptable salt or solvate thereof, or any mixture thereof. As used herein, the terms "analog" and "derivative" refer to a polypeptide having a molecular structure that is formally derivable from the structure of a naturally occurring peptide, e.g., the structure of human insulin, by deletion and / or replacement of at least one amino acid residue present in the naturally occurring peptide and / or by addition of at least one amino acid residue. The added and / or replaced amino acid residue can be either a codable amino acid residue or another naturally occurring residue or a purely synthetic amino acid residue. Insulin analogs are also referred to as "insulin receptor ligands". In particular, the term "derivative" refers to a polypeptide having a molecular structure formally derivable from the structure of a naturally occurring peptide, e.g., the molecular structure of human insulin in which one or more organic substituents (e.g., fatty acids) are attached to one or more of the amino acids. Optionally, one or more amino acids present in the naturally occurring peptide are deleted and / or replaced by other amino acids, including non-codeable amino acids, or amino acids, including non-codeable ones, are added to the naturally occurring peptide.
[0092] Examples of insulin analogues are Gly(A21), Arg(B31), Arg(B32) human insulin (insulin glargine); Lys(B3), Glu(B29) human insulin (insulin glulisine); Lys(B28), Pro(B29) human insulin (insulin lispro); Asp(B28) human insulin (insulin aspart); human insulin in which the proline in position B28 may be replaced by Asp, Lys, Leu, Val or Ala and in which the Lys in position B29 may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.
[0093] Examples of insulin derivatives are e.g. B29-N-myristoyl-des(B30) human insulin, Lys(B29)(N-tetradecanoyl)-des(B30) human insulin (insulin detemir, Levemir®); B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoyl-LysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin. ; B30-N-palmitoyl-ThrB29LysB30 human insulin; B29-N-(N-palmitoyl-gamma-glutamyl)-des(B30) human insulin, B29-N-omega-carboxypentadecanoyl-gamma-L-glutamyl-des(B30) human insulin (insulin degludec, Tresiba®); B29-N-(N-lithocholyl-gamma-glutamyl)-des(B30) human insulin; B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin and B29-N-(ω-carboxyheptadecanoyl) human insulin.
[0094] Examples of GLP-1, GLP-1 analogs and GLP-1 receptor agonists are, for example, lixisenatide (Lyxumia®), exenatide (exendin-4, Byetta®, Bydureon®, a 39 amino acid peptide produced by the salivary glands of the flathead monster), liraglutide (Victoza®), semaglutide, taspoglutide, albiglutide (Syncria®), dulaglutide (Trulicity®), rExendin-4, CJC-1134-PC, PB-1023, TTP-054, langrenatide / HM-11260C (efpegrenatide). , HM-15211, CM-3, GLP-1 Erigen, ORMD-0901, NN-9423, NN-9709, NN-9924, NN-9926, NN-9927, Nodexene, Viador-GLP-1, CVX-096, ZYOG-1, ZYD-1, GSK-2374697, DA-3091, MAR-701, MAR709, ZP-2929, ZP-3022, ZP -DI-70, TT-401 (Pegapamodtide), BHM-034, MOD-6030, CAM-2036, DA-15864, ARI-2651, ARI-2255, Tirzepatide (LY3298176), Bamadutide (SAR425899), Exenatide-XTEN and Glucagon-Xten.
[0095] Examples of oligonucleotides are, for example, the cholesterol-lowering antisense therapeutic mipomersen sodium (Kynamro®) for the treatment of familial hypercholesterolemia, or RG012 for the treatment of Alport Syndrome.
[0096] Examples of DPP4 inhibitors are linagliptin, vidagliptin, sitagliptin, denagliptin, saxagliptin, berberine.
[0097] Examples of hormones include pituitary or hypothalamic hormones or regulatory active peptides and their antagonists, such as gonadotropins (follitropin, lutropin, chorion gonadotropin, menotropin), somatropine (somatropin), desmopressin, terlipressin, gonadorelin, triptorelin, leuprorelin, buserelin, nafarelin, and goserelin.
[0098] Examples of polysaccharides include glycosaminoglycans, hyaluronic acid, heparin, low molecular weight heparin or very low molecular weight heparin or derivatives thereof, or sulfated polysaccharides, such as the above-mentioned polysaccharides in polysulfated form, and / or their pharma- ceutically acceptable salts. An example of a pharma-ceutically acceptable salt of polysulfated low molecular weight heparin is enoxaparin sodium. An example of a hyaluronic acid derivative is Hylan G-F20 (Synvisc®), sodium hyaluronate.
[0099] The term "antibody" as used herein refers to an immunoglobulin molecule or an antigen-binding portion thereof. Examples of antigen-binding portions of an immunoglobulin molecule include F(ab) and F(ab')2 fragments that retain the ability to bind to an antigen. An antibody can be a polyclonal antibody, a monoclonal antibody, a recombinant antibody, a chimeric antibody, a deimmunized or humanized antibody, a fully human antibody, a non-human (e.g., murine) antibody, or a single chain antibody. In some embodiments, an antibody has effector function and is capable of fixing complement. In some embodiments, an antibody has reduced or no binding ability to Fc receptors. For example, an antibody can be an isotype or subtype, an antibody fragment, or a mutant that does not support binding to Fc receptors, e.g., with a mutation or deletion of the Fc receptor binding region. The term antibody also includes antigen-binding molecules based on tetravalent bispecific tandem immunoglobulins (TBTI) and / or dual variable region antibody-like binding proteins (CODV) with crossover binding region orientation.
[0100] The term "fragment" or "antibody fragment" refers to a polypeptide (e.g., antibody heavy and / or light chain polypeptide) derived from an antibody polypeptide molecule that does not include the full-length antibody polypeptide but comprises at least a portion of the full-length antibody polypeptide that is still capable of binding to an antigen. An antibody fragment can include truncated portions of a full-length antibody polypeptide, but the term is not limited to such truncated fragments. Antibody fragments useful in the present invention include, for example, Fab fragments, F(ab')2 fragments, scFv (single-chain Fv) fragments, linear antibodies, monospecific or multispecific antibody fragments, such as bispecific, trispecific, tetraspecific and multispecific antibodies (e.g., diabodies, triabodies, tetrabodies), monovalent or multivalent antibody fragments, such as bivalent, trivalent, tetravalent and multivalent antibodies, minibodies, chelating recombinant antibodies, tribodies or bibodies, intrabodies, nanobodies, small modular immunopharmaceuticals (SMIPs), binding domain immunoglobulin fusion proteins, camelized antibodies, and VHH-containing antibodies. Additional examples of antigen-binding antibody fragments are known in the art.
[0101] The term "complementarity determining region" or "CDR" refers to short polypeptide sequences in the variable regions of both heavy and light chain polypeptides that are primarily responsible for mediating specific antigen recognition. The term "framework region" refers to amino acid sequences in the variable regions of both heavy and light chain polypeptides that are not CDR sequences and are primarily responsible for maintaining the proper arrangement of the CDR sequences to allow antigen binding. Although the framework region itself typically does not directly participate in antigen binding, as is known in the art, certain residues in the framework region of a particular antibody may be directly involved in antigen binding or may affect the ability of one or more amino acids in the CDR to interact with the antigen.
[0102] Exemplary antibodies are anti-PCSK-9 mAb (eg, alirocumab), anti-IL-6 mAb (eg, sarilumab), and anti-IL-4 mAb (eg, dupilumab).
[0103] Pharmaceutically acceptable salts of any of the APIs described herein are contemplated for use in the drug or medicament in the drug delivery device. Pharmaceutically acceptable salts include, for example, acid addition salts and base salts.
[0104] It will be understood by those skilled in the art that modifications (additions and / or deletions) can be made to the various components of the APIs, formulations, devices, methods, systems, and embodiments described herein without departing from the full scope and spirit of the invention, and that the invention encompasses such modifications and all equivalents thereof.
[0105] It will be further apparent to those skilled in the art that various modifications and changes can be made to the present disclosure without departing from the scope of the present disclosure. Furthermore, it should be noted that any reference numbers used in the appended claims should not be construed as limiting the scope of the present disclosure.
[0106] Below, numerous examples of methods for controlling electronically implemented functions of a drug delivery device or associated with a drug delivery device, as well as numerous hardware configurations including numerous implementations of authentication systems, electronic circuits, drug delivery devices, auxiliary devices, and mobile electronic devices, are described in more detail with reference to the drawings. [Brief description of the drawings]
[0107] [Figure 1] FIG. 1 depicts an example of a drug delivery device implemented as a pen injection device. [Diagram 2] FIG. 2 shows an injection device with an auxiliary device. [Diagram 3] FIG. 1 is a longitudinal cross-sectional view of an example of a pen injection device. [Figure 4]FIG. 1 illustrates a number of hardware components of an authentication system. [Diagram 5] FIG. 1 is a block diagram of an example of an authentication system. [Figure 6] FIG. 2 is a block diagram of another implementation of an authentication system. [Figure 7] FIG. 2 is a block diagram of a further implementation of the authentication system. [Figure 8] FIG. 13 is a block diagram of an auxiliary device attached to an injection device operable to communicate with at least one or more mobile electronic devices. [Figure 9] FIG. 13 is a diagram illustrating wireless communication between a mobile electronic device and an electronic unit of a drug delivery device. [Figure 10] FIG. 2 is a schematic representation of different users to which different data records are provided and assigned; [Figure 11] 1 is a flow diagram of a method for authenticating a user who uses a drug delivery device. [Figure 12] FIG. 13 shows a comparison between acquired and memorized motion data. [Figure 13] 13 is a flow diagram of a further implementation of a method for authenticating a user. [Figure 14] 4 is a further flow diagram of a method for authenticating a user. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0108] In figures 1 to 3 an example of a drug delivery device 1 implemented as an injection device is represented diagrammatically. The drug delivery device 1 comprises an elongated housing 16, for example cylindrical or tubular. The housing 16 extends along a longitudinal direction. Towards the distal direction 2 and thus the distal end an injection needle 19 can be attached to a container housing 18 forming or constituting the distal part of the housing of the injection device 10. Towards the proximal direction 3 and thus the proximal end of the injection device 10 a dose dial 12 and / or a dose button 14 are provided which respectively allow the setting of a dose of medicament 8 and the dispensing of the dose.
[0109] The container housing 18 is configured and shaped to receive the drug container 5. The drug container 5 may include a tubular barrel. The drug container 5, for example implemented as a standard cartridge, may be sealed towards the proximal direction 3 by a movable stopper 6. The distal end of the drug container 5 is typically sealed by a pierceable seal 7. The outlet of the drug container 5 is thus covered by the pierceable seal, which is secured to the head of the drug container 5 by, for example, a crimp cap (not shown).
[0110] The injection device 10 further comprises a drive mechanism 11. The drive mechanism 11 comprises a piston rod 24 of elongated shape extending along the longitudinal direction of the housing 16. Inside the housing 16, an inner body 15 may be provided, which serves as a support or mounting for the drive mechanism 11. The piston rod 24 may be threadably engaged with the inner body 15. Thus, a rotation of the piston rod 24 induced by the drive mechanism 11 may result in a forward movement of the piston rod 24 relative to the inner body 15 and the housing 16, which may urge or move the stopper 6 in the distal direction 2 against the drug container 5. Thus, a dose of drug 8 may be expelled from the outlet of the drug container 5. Typically, the seal 7 may be pierceable by a double-ended injection needle 19, represented in Figs. 4 and 5. The injection needle may, for example, comprise a threaded needle hub and may be detachably or releasably connected to the distal end of the container housing.
[0111] The drive mechanism 11 typically includes a number sleeve 21 that is at least partially visible through a window 20 provided in the housing 16 of the injection device 10. When a dose is set, the number sleeve 21 undergoes a rotational movement. In response, a series of increasing dose numbers may appear in the window 20 to indicate the size of the dose currently set. The drive mechanism 11 further includes a drive sleeve 22. The drive sleeve 22 is operably connected or coupled to a piston rod when the drive mechanism 11 is in a dose dispensing or dose injection mode. Rotation of the drive sleeve 22 may be initiated by pressing the dose button 14, which is operably connected to the piston rod 24 by actuation of a clutch to induce a dose dispensing rotation and a distal longitudinal forward movement of the piston rod 24.
[0112] The piston rod 24 includes a push piece 25 at its distal end. The push piece 25 is typically supported non-rotatably at the distal end of the piston rod 24. The push piece 25 transmits the distal thrust applied by the piston rod 24 to the proximal thrust receiving surface of the stopper 6. In some examples, the drive mechanism 11 includes a mechanical energy store, such as a spring. The mechanical energy store can be activated during or when the dose is set. Depressing the dose button 14 can release mechanical energy stored in the mechanical energy store and provide a drive torque or force capable of advancing the piston rod 24 in the distal direction 2 to dispense a dose of the medicament 8. In other examples, the drive mechanism 11 does not include a mechanical energy store. Here, the force applied by the user to the dose button 14 is almost completely transmitted to the drive force required to move the piston rod 24 in the distal direction.
[0113] An exemplary drug delivery device may involve a needle-based injection system as described in Table 1 of Chapter 5.2 of ISO11608-1:2014(E). As described in ISO11608-1:2014(E), needle-based injection systems can be broadly differentiated into multi-dose container systems and single-dose (partial or full expulsion) container systems. The container may be an exchangeable container or an integrated non-exchangeable container.
[0114] As further described in ISO11608-1:2014(E), a multi-dose container system can involve a needle-based injection device with an exchangeable container. In such a system, each container holds multiple doses and the dose size can be fixed or variable (pre-set by the user). Another multi-dose container system can involve a needle-based injection device with an integrated non-exchangeable container. In such a system, each container holds multiple doses and the dose size can be fixed or variable (pre-set by the user).
[0115] The drive mechanism 11 described above is merely exemplary of one of several different configurations of drive mechanisms that can generally be implemented in a disposable or reusable pen injector. The drive mechanism described above is described in more detail, for example, in WO2004 / 078239A1, WO2004 / 078240A1, or WO2004 / 078241A1, which are incorporated herein by reference in their entirety. Further examples of drive mechanisms 11 implemented with the injection device 10 can be found in WO2014 / 033195A1 or WO2014 / 033197A1, which are incorporated herein by reference in their entirety. The drive mechanism disclosed in WO2014 / 033195A1 is a reusable drive mechanism. The drive mechanism disclosed in WO2014 / 033197A1 is an example of a disposable drive mechanism that does not include a reset function.
[0116] In Fig. 4, a number of components of the authentication system 1000, which are described below, are represented diagrammatically. The injection device 10 may comprise an electronic unit 60. The electronic unit 60 typically comprises an electronic circuit 61. The electronic circuit 61 comprises a processor 62 and a battery 63. Furthermore, in a typical example, the electronic unit 60 embedded or integrated in the injection device 10 may also comprise a storage 64, a sensor 65, a communication interface 66, a proximity sensor 67, a signal unit 68.
[0117] As shown in FIG. 4, the electronic unit 60 can be disposed within the dose dial 12. The dose button 14 can close a receptacle of the dose dial 12, the receptacle being sized to accommodate at least a portion of the electronic unit 60. As further represented in FIG. 4, the authentication system 1000 can include at least one mobile electronic device 80, 100, 120. The mobile electronic device 80 can be implemented as an external electronic device. The mobile electronic device 80 can constitute a smartphone. The smartphone 80 typically includes an input 89 and a display 91. Here, the input 89 can be integrated into the display 91, and thus the display 91 is implemented as a touch-sensitive display. In another example, the mobile electronic device 100 is implemented as a wearable electronic device. The wearable electronic device 100 can include a strap 112 or a wristband that allows the mobile electronic device 100 to be attached, for example, to a user's wrist. The mobile electronic device 100 can be implemented as a smart watch.
[0118] Typically, the mobile electronic device includes a housing 110 that houses an electronic circuit 101 with a processor 102, a battery 103, a storage 104, a sensor 105, a communication interface 106, a proximity sensor 107, and a signal unit 108. The housing 110 can be closed or covered by a display 111. In some examples, the mobile electronic device 100 can be attached to the wrist or arm of a user 4. In other examples, the mobile electronic device 100' can be attached to another part of the user's body. As an example, the mobile electronic device 100' can be implemented as a belt or integrated into the user's belt.
[0119] The mobile electronic device 120 may be implemented as a radio tag. The radio tag 120 may include a housing 129. Typically, the radio tag 120 includes an electronic circuit 121, which may include, for example, a printed circuit board. The electronic circuit 121 may include at least one of a processor 122, a battery 123, a sensor 125, a communication interface 126, a proximity sensor 127, and a signal unit 128. The mobile electronic device 120 is typically carried by a user 4.
[0120] In some examples, the mobile electronic device 120 may be permanently attached to a personal item of the user, such as a key. In a further example, the mobile electronic device 120 may be attached to the drug delivery device 1.
[0121] 5, the drug delivery device 1, and thus the injection device 10, further comprises a movable member 26. The movable member 26 may be implemented in the drive mechanism 11. Movable components of the drive mechanism 11 may form or constitute the movable member 26. The movement or position of the movable member 26 of the drive mechanism 11 may be detected or tracked by the electronic unit 60 of the injection device 10.
[0122] The detectable position or orientation of the movable member 26 may indicate a current state or configuration of the injection device 10. The position of the movable member 26 along the longitudinal direction may directly indicate the remaining amount of medicament 8 provided in the medicament container 5. By detecting or quantitatively measuring at least one of the position or orientation of the movable member 26, the electronic unit 60 may gather device specific information regarding the instantaneous state or configuration of the injection device. Thus, the electronic unit 60 may be configured to collect and / or gather data indicative of the operational state or usage history of the injection device 10. The electronic unit 60 may collect data such as a dosing or dosing history including information regarding the amount of medicament dispensed on a particular date and / or time.
[0123] The injection device 10 may further comprise an electromechanical interlock 30. The electromechanical interlock 30 may be integrated in the drive mechanism 11. The interlock 30 may be operable by an electronic unit 60 of the injection device 10.
[0124] 5, the injection device 10 comprises an electronic unit 60. The electronic unit 60 includes, for example, a printed electronic circuit 61, a processor 62, a battery 63, a storage 64, at least one sensor 65, a communication interface 66, a proximity sensor 67, and / or a signal unit 68.
[0125] The signal unit 68 is configured to generate a signal perceptible by a user. The signal unit 68 may include a speaker for generating an audible signal. The signal unit 68 may include a display for visualizing information to a user. The signal unit 68 may include a flashing light, such as an LED. The signal unit 68 may include multiple LEDs or light sources configured to generate light indications or light pulses of different colors and / or durations. The signal unit 68 may also include a buzzer or similar electromechanical unit for generating a vibration or some other tactilely detectable signal.
[0126] The communication interface 66 is configured to communicate with another communication interface 86 of the mobile electronic device 80. Alternatively or additionally, the communication interface 66 is configured to communicate with a database 140 via a network 130. The communication interface 66 can access the database 140 and / or the network 130 by means of a specific access point 131. The communication between the communication interface 66 and the network 130 is typically implemented as a wireless communication link.
[0127] The mobile electronic device 80 can be implemented as a smartphone. The mobile electronic device 80 includes an electronic circuit 81, a processor 82, a battery 83, a storage 84, a sensor 85, a communication interface 86, a proximity sensor 87, a signal unit 88, a user operable input 89, a housing 90, and a display 91. The mobile electronic device 80 can be configured to communicate with a satellite positioning system 95 to gather global or regional location information. Typically, the communication interface 86 of the mobile electronic device 80 is configured to communicate with a network 130 by at least one of several access points. The communication interface 86 can communicate with a database 140 to gather or receive requested data from the database 140.
[0128] In a further example of an authentication system 1000 depicted in Fig. 6, not only one mobile electronic device 80 but also a further mobile electronic device 100 is provided, for example in the form of a smart watch or a fitness tracker. The mobile electronic device 100 also includes at least one of an electronic circuit 101, a processor 102, a battery 103, a storage 104, a sensor 105, a communication interface 106, a proximity sensor 107, and a signal unit 108. All these components may be enclosed within a housing 110. The signal unit 108 may include a display 111. The signal unit 108 may be implemented in the same or similar manner as the signal unit 68 described above in relation to the electronic unit 60.
[0129] The mobile electronic device 100 is operable to communicate with the network 130 and the database 140 via the communication interface 106. The mobile electronic device 100 can also wirelessly communicate with the electronic unit 60 of the drug delivery device 1 as well as the communication interface 86 of the mobile electronic device 80. In a further example, the mobile electronic device 100 can also directly or indirectly communicate with a satellite positioning system 95 to obtain geographical location data, e.g., to obtain absolute or relative location data of the mobile electronic device 100.
[0130] In a further example depicted in Fig. 7, the drug delivery device 1 may not include the above-mentioned electronic unit 60. The injection device 10 and / or the drive mechanism 11 can all be implemented mechanically. Here, the injection device 10 may comprise an auxiliary device 40. The auxiliary device 40 typically includes a fastener 49 for removably fastening or fixing the auxiliary device 40 to the housing 16 of the injection device 10.
[0131] The auxiliary device 40 includes a signal unit 48. The signal unit 48 may include one of a light source, for example in the form of a flashing light, a display, a speaker, and a vibration generating unit. When implemented as a display or a flashing light, the signal unit 48 may provide a visual information or a visual warning to the user. Typically, the auxiliary device 40 also includes at least one of an electronic circuit 41, a processor 42, a battery 43, a storage 44, a sensor 45, a communication interface 46, and a proximity sensor 47. In a typical example, the auxiliary device 40 is operably connected or coupled to the interlock 30 of the drive mechanism 11 when attached to the injection device 10.
[0132] Additionally or alternatively, the auxiliary device 40, and in particular its sensor 45, may be operatively connected or coupled to the movable member 26 of the drive mechanism 11. Thus, the auxiliary device 40 is operable to acquire or obtain information regarding an instantaneous state of the drive mechanism 11 which is reflected in the position, orientation or movement of the movable member 26. Similarly, as described above in relation to the electronic unit 60 or the mobile electronic device 100, the auxiliary device 40 is operable to wirelessly communicate with the mobile electronic devices 80, 100, 120.
[0133] The auxiliary device 40 may also be operable to communicate directly with the database 140 via the communication network 130. As further represented in Fig. 8, the auxiliary device 40 and / or the electronic unit 60 of the injection device 10 may be operable to communicate with at least one or some of the mobile electronic devices 80, 100, 120. A wireless communication link may be established between at least two of the electronic unit 60, the auxiliary device 40, the mobile electronic device 80, the mobile electronic device 100, and the mobile electronic device 120. Furthermore, the mobile electronic devices 80, 100, 120 may communicate between each other.
[0134] A first wireless communication link may be established between at least one of the electronic unit 60 and the auxiliary device 40 and one of the mobile electronic devices 80, 100, 120. Further wireless communication links may be established between any of the electronic unit 60, the auxiliary device 40, the mobile electronic devices 80, 100, 120 and the communication network 130 and / or the database 140.
[0135] The sensors 45, 65, 85, 105, 125 may be implemented as one of an acceleration sensor, a rotation sensor, a position sensor, a distance sensor, and a physiological data capture sensor. An implementation of the physiological data capture sensor typically comprises a wearable electronic device 80, 100, 120. The sensors 45, 64, 85, 105, 125 may obtain motion data of the respective electronic circuits 41, 61, 81, 101, 121.
[0136] Each athletic data may be stored in an associated storage 44, 64, 84, 104, 124 of the respective electronic circuit 61. The acquired athletic data may also be communicated and / or transmitted to another electronic circuit 41, 61, 81, 101, 121 via a communication interface 46, 66, 86, 108, 126. The athletic data of the user 4 may also be obtained by establishing a communication link with a database 140 via a network 130. The athletic data collected by any of the sensors 45, 65, 85, 105, 125 may be stored in the database 140 and made available to any other electronic circuit 41, 61, 81, 101, 121.
[0137] Additionally, at least a portion of the athletic data may be acquired or collected, for example, by a first mobile electronic device 100 , 120 carried by a user 4 .
[0138] Further portions of the athletic data can be acquired and collected by sensors 44, 65 attached to or integrated with the injection device 10. Different portions of the athletic data can be combined and collected by wireless communication links between the respective mobile electronic devices 80, 100, 110 and at least one of the auxiliary device 40 and the electronic unit 60. Any of the wireless communication interfaces 46, 66, 86, 106, 126 can be operable to transmit and receive (transmit and / or receive) within a specific frequency range according to a specific transmission protocol. The wireless communication interface can include multiple communication circuits, each of which transmits and receives within a different frequency range and / or according to a different wireless transmission protocol.
[0139] At least one or some of the wireless communication interfaces 46, 66, 86, 106, 126 described herein include at least one RFID communication circuit (radio frequency identification). The wireless communication interface may include an NFC circuit (near field communication), for example an active NFC circuit (preferably having an associated power source, e.g. a battery such as a printable battery), or a passive NFC circuit (preferably having no power source powering the circuit). The wireless communication interface may include at least one Bluetooth and / or BLE communication circuit (Bluetooth Low Energy). The wireless communication unit may include at least one WiFi communication circuit (wireless fidelity, e.g. compliant with IEEE 802.11 standard / protocol). Alternatively or additionally, the wireless communication unit may include a magnetometer / compass circuit to detect variations in a magnetic field, e.g. variations caused by a wireless communication circuit of a component of the drug delivery device.
[0140] In some examples, at least one or some of the wireless communication interfaces 46, 66, 86, 106, 126 described herein are implemented as UWB (Ultra Wideband) communication interfaces.
[0141] At least one of the wireless communication interfaces 46, 66, 86, 106, 126 is configured to generate an UWB signal that enables communication with another of the wireless communication interfaces 46, 66, 86, 106, 126. The UWB signal includes very short RF pulses (e.g., less than 1 nanosecond) that cover a large portion of the radio spectrum (e.g., a bandwidth greater than 500 MHz or 20% of the center frequency, whichever is lower) at a very low energy level. The operating frequency is selected according to one or more national and federal regulations. For example, a frequency band that is widely accepted internationally is about 6.5 GHz to about 8 GHz. In some implementations, the UWB signal includes the UWB standard that is widely accepted and available for smartphones from large distributors, so that a standard smartphone can be used as the mobile electronic device 80.
[0142] In some implementations, the UWB communication includes a proprietary UWB protocol. The proprietary UWB protocol uses a coding that consists of a combination of time modulation, signal shape modulation, and amplitude modulation. A proprietary UWB device (e.g., a USB dongle for a smartphone) can be used as the wireless tag 120. The transmission of the UWB signal can be triggered by a user action.
[0143] In some examples, as depicted in Fig. 9, wireless communication between at least one of the injection device 10 and the auxiliary device 40 and at least one of the mobile electronic devices 80, 100, 120 provides a pager function. For example, in principle, when a communication link is established by using UWB communication protocols, precise location tracking of the electronic unit 60 can be provided. Thus, the location of at least one of the drug delivery device 10 and the auxiliary device 40 can be precisely determined or measured within an accuracy range of just a few centimeters or even millimeters.
[0144] Additionally or alternatively, the wireless communication link may also provide for determination and / or quantitative measurement of at least one of the distance and relative position between the first electronic circuit and the second electronic circuit, e.g., the distance and the position or relative position between the injection device 10 and one of the mobile electronic devices 80, 100, 120.
[0145] As shown in FIG. 9 , the mobile electronic device 80 includes a communication interface 86 with an antenna 96, a distance unit 97, and a location unit 98. The antenna 96 is implemented, for example, as a UWB antenna and is operable to communicate with the electronic unit 60 and, alternatively, with the electronic circuit 41 of the auxiliary device 40. In some examples, the antenna 96, and thus the communication interface 86, is operable to wirelessly communicate with the communication interface 66 and / or the proximity sensor 67 of the electronic unit 60. The UWB antenna 96 is not limited to being implemented within the mobile electronic device 80. The antenna 96, the distance unit 97, and the location unit 98 are configured to generate and / or process UWB signals for accurate position and distance measurement between any two mobile electronic devices 80, 100, 120 and / or electronic circuits 41, 61, and can be implemented in any of the communication interfaces 46, 66, 106, 126 as well.
[0146] The antenna 96 can be configured such that the time characteristics of the UWB signal are constant over the frequency spectrum, resulting in minimal pulse distortion. The antenna 96 can exhibit a fairly flat frequency spectrum, resulting in wide pulses with minimal resonance distortion. The antenna 96 can be integrated into any one of the communication interfaces 46, 66, 86, 106, 126, typically near the surface of the respective housing to have minimal attenuation of the signal. A possible implementation of the antenna 96 is the integration of a chip antenna or the integration of a conductive layer acting as the antenna 96 in one of the plastic components of any one of the injection device 10, the auxiliary device 40, or any one of the mobile electronic devices 80, 100, 120. The opposing communication interface 46, 66, 86, 106, 126 operable to communicate with the antenna 96 can be configured to receive the incoming data packets transmitted by the antenna 96, either constantly or intermittently.
[0147] A distance unit 97 operably coupled to the antenna 96 is capable of deriving or quantitatively measuring the distance between the electronic unit 60 and the communication interface 86, and thus between the electronic unit 60 and the device 80, based on at least one of signal dispersion, time-of-flight measurements, dynamic or static triangulation, or based on any further generally available distance or position measurement scheme compatible with the respective wireless communication protocol.
[0148] The antenna 96 may be implemented as an array antenna capable of determining the direction in which a signal or a response signal from the electronic unit 60 is received. A wireless communication link between the mobile electronic device 80 and one of the electronic unit 60 and the auxiliary device 40 may provide not only distances such as 1.5 m but also the direction and therefore the relative positions between the devices 10, 40 and 80 in the form of visible symbols, for example on the display 91 of the mobile electronic device 80, thus assisting the user 4 in finding or retrieving the electronic unit 60 if the respective device is missing or if the user is not currently aware of where the injection device 10 can be found.
[0149] In Fig. 10 a data record 250 of a first person 4 and another data record 250' of another person 4' are represented. The data records 250, 250' include movement data 251, 251'. The movement data 251 includes at least one of gesture data 252 and movement patterns 254 of the user 4. The gesture data 252 is specific to a particular movement or gesture performed or executed by the user 4, for example the way the user walks or the way the user picks up a device.
[0150] The movement pattern 254 may be specific to or indicative of the movement profile of each user 4. The movement pattern 254 may contain information about the user's habits. For example, the movement pattern 254 may indicate that a particular user A is in his / her residential environment on a particular day of the week and remains there during a particular time interval, e.g., overnight.
[0151] The motion pattern 254 may contain a typical motion profile and may provide a mapping of the user's location over time. Optionally, the data record 250 may also include a user identification 256. The user identification 256 may contain a unique identifier for the user. The data record 250 may be subject to permanent updates when the user 4 is equipped with a mobile electronic device 80, 100, 120 that is not capable of capturing and / or acquiring respective motion or movement data over time.
[0152] The data records 250 include athletic data 251 and are stored in any of the storages 44, 64, 84, 104, 124 discussed above. The data records 250 may be available upon request, for example, when the authentication system 1000 performs a comparison of actual or newly acquired athletic data 261 with previously stored athletic data 251 to determine or derive a data match index 270.
[0153] As further depicted in Figure 10, another user B includes another data record 250', which may be constructed similarly to data record 250. Data record 250' also includes gesture data 252', movement patterns 254', and possibly a user identification 256'. Movement data 251 is specific to a first user 4, and movement data 251' is specific to another user 4'.
[0154] In the flow chart according to Fig. 11 an example of a method for controlling electronically implemented functions of and / or associated with the drug delivery device 1 or injection device 10 is represented diagrammatically. In a first step 200, a distance is measured between a drug delivery device associated with or comprising the above mentioned electronic circuit 41, 61 and at least one of the mobile electronic devices 80, 100, 120. Wireless communication between the mobile electronic device 80, 100, 120 and the electronic circuit 41, 61 is used to determine or measure the distance and / or the relative position between the electronic circuit 41, 61 and the mobile electronic device 80, 100, 120.
[0155] If, at step 202, the distance falls below a predefined acceptance distance, and thus below the respective threshold, the procedure proceeds to step 204. For example, if the distance falls below a predefined threshold distance, e.g. below a predefined acceptance distance, one of enabling, disabling, triggering, or terminating the electronic implementation functions of the electronic circuits 41, 61 and the electronic implementation functions of the drug delivery device 1 is performed by the processor 42, 62. In some examples, the electronic implementation functions of the electronic circuits 41, 61 are operable to engage the drive mechanism 11 of the injection device 10. Then, by the distance measurement, the electronic circuits 41, 61 can be operable to unlock or release the interlock 30 depending on the size of the distance measured between the mobile electronic device 80, 100, 120 and one of the electronic circuits 41, 61 of one of the auxiliary devices 40 attached to the drug delivery device 1 or the injection device 10.
[0156] If, in step 202, it is determined that the distance measured by wireless communication exceeds a predefined threshold, the procedure returns to step 200 to repeatedly measure the distance between the drug delivery device 1 and the mobile electronic device 80,100,120.
[0157] In a further example depicted in Fig. 13, in a first step 300, the distance between the electronic circuit 41, 61 integrated in or attached to the drug delivery device 1 is measured and / or determined. In a next step 302, the distance is evaluated or analyzed. There, it is determined whether the distance is below a first predefined threshold. If the evaluation in step 202 reveals that the distance is below the first predefined distance threshold, the procedure proceeds to step 304. If in step 302, it is determined that the distance is above the first predefined threshold, the procedure returns to step 300.
[0158] In step 304, when the distance is therefore within a predetermined range, wireless communication between the communication interface 46, 66 of the electronic circuit 41, 61 and the mobile electronic device 80, 100, 120 is further used to locate the injection device and / or the mobile electronic device, where the relative position between the electronic circuit 41, 61 and the mobile electronic device 80, 100, 120 is determined or measured.
[0159] The relative position indicates the vector, and therefore the direction, of the shortest distance between the electronic circuit 41, 61 attached to or integrated in the drug delivery device 1 and the mobile electronic device 80, 100, 120. After the relative position is determined or calculated based on wireless signals exchanged between the communication interface 46, 66 and the opposing or mobile communication interface 86, 106, 126, the respective position or location information is provided to the user of the mobile electronic device 80, 100, 120 and / or the user 4 of the drug delivery device 1.
[0160] The information may be provided to the user 4, for example by a signal unit 88, 108, 128 operable to generate a user perceptible signal, enabling the user to identify and / or locate the drug delivery device comprising the electronic circuit 41, 61. Here, wireless communication between the electronic circuit 41, 61 and the mobile electronic device 80, 100, 120 may be used to provide a sort of electronic pager functionality, thereby assisting the user in locating the drug delivery device if it is missing or if the user is not aware where the injection device 10 or drug delivery device 1 has been recently stored or used.
[0161] Optionally, in a further step 308, a further distance measurement is performed by wireless communication between the electronic circuit 41, 61 and the mobile electronic device 80, 100, 120. Here, it may be determined whether the distance is below a second distance threshold. If in step 308 it is determined that the distance is below a second predetermined minimum threshold, the procedure may proceed to step 310, whereby access to the electronically implemented functions of the electronic circuit 41, 61 or the electronic functions of the drug delivery device 1 may be granted.
[0162] Such a double distance measurement or distance evaluation in steps 302, 308 is beneficial since a general authorization of a user with his / her mobile electronic device 80, 100, 120 can already be provided when he / she is within a predefined spatial vicinity of the drug delivery device 1. If the distance between the mobile electronic device 80, 100, 120 is within a first distance or range, a general user authentication procedure can be performed and, due to the limited distance between the devices, only a limited or reduced amount of electrical energy can be consumed compared to a situation where the authentication routine is performed at a relatively large distance between the mobile electronic device and the drug delivery device 1.
[0163] The distance is intended to be within a second or smaller range in order to finally approve the execution of the electronically implemented function. In this way, when the mobile electronic device 100, 120 is implemented as a wearable electronic device, such as a smart watch, it is possible to control whether the user is holding the drug delivery device in the correct way. For example, based on this second distance check performed in step 308, it is possible to measure or detect whether the injection device 10 is held in the same hand of the user 4 as the wearable electronic device 100, 120 is attached to. In this way, patient safety as well as compliance with the intended or prescribed use of the injection device can be enhanced.
[0164] In a further example according to Fig. 14, the procedure for controlling electronically implemented functions of or associated with the drug delivery device 1 starts with a first step 400, in which a distance between the electronic circuit 41, 61 and the mobile electronic device 80, 100, 120 is measured or determined. In a next step 402, it is checked or evaluated whether the measured or determined distance is below a predefined first distance threshold. If the distance is above the threshold, the procedure returns to step 400. If in step 402 it is determined that the distance is below the first distance threshold, the procedure proceeds to step 404. In step 404, at least one of the mobile electronic device 80, 100, 120 and / or the electronic circuit 41, 61 is operable or triggered to perform the user authentication procedure described above.
[0165] User authentication may be based on receiving or exchanging and evaluating an identification signal. Alternatively or additionally, the user may be identified by performing, analysing or evaluating the user's athletic data as described above.
[0166] In the next step 406 it is determined whether the user 4 is authorized to use the drug delivery device 1. If user authentication fails in step 406, device functionality may be disabled, for example an electronic implementation of the electronic circuitry 41, 61 of the delivery device 1, the injection device 10 or one of the auxiliary devices 40. The procedure may then return to step 404.
[0167] If the user authentication is approved in step 406, the procedure proceeds to step 410. Here, the distance between the mobile electronic device 80, 100, 120 and the electronic circuit 41, 61 is again determined or measured. Then, in a further step 412, a further distance measurement is performed by wireless communication between the electronic circuit 41, 61 and the mobile electronic device 80, 100, 120. Here, it can be determined whether the distance is below a second distance threshold. If in step 412, it is determined that the distance is below a second predetermined minimum threshold, the procedure can proceed to step 414, thereby authorizing access to the electronic implementation functions of the electronic circuit 41, 61 or the electronic functions of the drug delivery device 1. Here, the second distance measurement performed by steps 410, 412 can closely correspond to the distance measurement described above in relation to steps 304 and 308 of FIG. 13. [Explanation of symbols]
[0168] 1. Drug Delivery Devices 2 Distal direction 3 Proximal direction 4 User 5. Drug containers 6 Stopper 7 Sealing 8. Drugs 10 Injection Device 11 Drive mechanism 12 Dose Dial 14 Dose Button 15 Inner body 16 Housing 17 Protective Cap 18 Container housing 19 Syringe needle 20. Windows 21 Number Sleeve 22 Drive sleeve 24 Piston rod 25 Pressing piece 26 Movable parts 30 Interlock 40 Auxiliary Devices 41 Electronic circuit 42 processors 43 Batteries 44 Storage 45 Sensors 46 Communication Interface 47 Proximity Sensor 48 Signal Unit 49 Fasteners 50 Housing 51 Display 60 Electronic Unit 61 Electronic circuit 62 processors 63 Batteries 64 Storage 65 Sensors 66 Communication Interface 67 Proximity Sensor 68 Signal Unit 80 Mobile Electronic Devices 81 Electronic circuit 82 processors 83 Batteries 84 Storage 85 Sensors 86 Communication Interface 87 Proximity Sensor 88 Signal Unit 89 Input 90 Housing 91 Display 95 Satellite Positioning System 96 Antenna 97 Distance Units 98 Position Detection Unit 100 Mobile Electronic Devices 101 Electronic circuits 102 processors 103 Batteries 104 Storage 105 Sensors 106 Communication Interface 107 Proximity Sensor 108 Signal Unit 110 Housing 111 Display 112 Strap 120 Mobile Electronic Devices 121 Electronic circuits 122 processors 123 Batteries 125 Sensors 126 Communication Interface 127 Proximity Sensor 128 Signal Unit 129 Housing 130 Network 131 Access Points 140 Databases 250 data records 251 Exercise Data 252 Gesture Data 254 Movement Pattern 256 User Identification 260 data records 261 Exercise Data 262 Gesture Data 264 Movement Patterns 266 User Identification 270 Integrity Index 1000 Authentication System
Claims
1. An electronic circuit for a drug delivery device (1), the drug delivery device operable to dispense a medication (8), the electronic circuit (41, 61) comprising: a communication interface (46, 66) operable to wirelessly communicate with the mobile electronic device (80, 100, 120) and transmit at least wireless signals to the mobile electronic device, the wireless signals enabling at least one of a distance and a relative position between the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120) to be determined; a processor (42, 62) operatively connected to said communication interface (46, 66) and operable to enable, disable, trigger or terminate execution of an electronically implemented function of the electronic circuit (41, 61) based on an analysis of at least one of the distance and the relative position; The electronic circuit comprising:
2. The electronic circuit of claim 1 , wherein the electronic circuit is operable to communicate with a mobile electronic device (80, 100, 120) to quantitatively measure a distance between the electronic circuit and the mobile electronic device.
3. 3. The electronic circuit of claim 2, wherein the processor (42, 62) is configured to not authorize access to electronically implemented features of the electronic circuit as long as the distance exceeds a predetermined authorization distance.
4. The electronic circuit of claim 1 , wherein the processor (42, 62) is further operable to analyze at least one of distance and relative position.
5. The electronic circuit (41, 61) of any one of claims 1 to 4, further comprising a proximity sensor (47, 67) operatively connected to the processor (42, 62) and operable to measure at least one of a distance and a relative position between the electronic circuit (41, 61) and a mobile electronic device (80, 100, 120).
6. The processor (42, 62) when the distance between the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120) is within a predetermined operating distance; and / or An electronic circuit (41, 61) according to any one of claims 1 to 5, operable to enable or trigger an electronically implemented function only when the electronic circuit (41, 61) is within a predetermined relative operating position with respect to the mobile electronic device (80, 100, 120).
7. The electronic circuit (41, 61) according to any one of claims 1 to 6, wherein at least one of the communication interface (46, 66) and the proximity sensor (47, 67) is implemented as a UWB (ultra-wideband) based interface or sensor, respectively, and configured to generate, transmit, receive and / or process electromagnetic ultra-wideband signals.
8. The processor (42, 62) is operable to generate a control command based on the analysis of at least one of the distance and the relative position, the control command being: generating a user perceptible warning or signal by a signal unit (48, 68); Locking or unlocking a drive mechanism (11) of the drug delivery device (1) by an electromechanical interlock (30); Triggering or terminating the transmission of data by the communication interface (46, 66); The electronic circuit (41, 61) according to any one of claims 1 to 7, configured to cause at least one of: switching the electronic circuit (41, 61) from a standby mode to an active mode or vice versa.
9. The communication interface (46, 66) is configured to exchange user specific data with the mobile electronic device (80, 100, 120), the user specific data being: Drug type, the time and / or date of the medication administration action; The amount of medication administered, An electronic circuit (41, 61) according to any one of the preceding claims, comprising at least one of motion data (251, 261) of a user (4).
10. A drug delivery device (1) operable to dispense a medication (8): a housing (16, 18) for receiving a drug container (5) filled with a drug (8); a drive mechanism (11) operably connectable to the medicament container (5) for discharging or drawing the medicament (8) from the medicament container (5); and an electronic circuit (61) according to any one of claims 1 to 9, integrated into the housing (16, 18) and / or operably connected to a drive mechanism (11).
11. An auxiliary device (40) for a drug delivery device (1), comprising: A housing (50); a fastener (49) for fastening the auxiliary device (40) to the housing (16, 18) of the drug delivery device (1); The auxiliary device comprises an electronic circuit (41) according to any one of claims 1 to 9.
12. A mobile electronic device (80, 100, 120) for use with a drug delivery device (1), comprising: a mobile communication interface (86, 106, 126) operable to wirelessly communicate with a communication interface (46, 66) of an electronic circuit (41, 61) according to any one of claims 1 to 9 associated with a drug delivery device (1) and operable to transmit at least a wireless signal to the communication interface (46, 66), the wireless signal enabling to determine at least one of a distance and a relative position between the electronic circuit (41, 61) and a mobile electronic device (80, 100, 120); a processor (82, 102, 122) operatively connected to the mobile communication interface (46, 66) and operable to enable, disable, trigger or terminate execution of an electronically implemented function of the mobile electronic device (80, 100, 120) based on an analysis of at least one of the distance and the relative position; The mobile electronic device comprising:
13. The mobile electronic device (80, 100, 120) of claim 12, further comprising a proximity sensor (87, 107, 127) operably connected to the processor (42, 62) and operable to measure at least one of a distance and a relative position between the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120).
14. 14. The mobile electronic device (80, 100, 120) of claim 12 or 13, wherein at least one of the mobile communication interface (86, 106, 126) and the proximity sensor (87, 107, 127) includes a UWB (Ultra Wideband) antenna (96) operable to transmit and receive ultra wideband signals.
15. the distance between the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120); and Relative position of electronic circuit (41, 61) to the position of the mobile electronic device (80, 100, 120) The mobile electronic device (80, 100, 120) of any one of claims 12 to 14, further comprising a signal unit (88, 108, 128) operable to indicate and / or represent to a user (4) at least one of the following:
16. A method for controlling electronically implemented functions of or associated with a drug delivery device (1), comprising: Establishing a wireless communication link between an electronic circuit (41, 61) attached to or integrated in the drug delivery device (1) and a mobile electronic device (80, 100, 120); determining at least one of a distance and a relative position between the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120) by transmission of wireless signals between the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120); analyzing or evaluating at least one of the distance and the relative position; and at least one of enabling, disabling, triggering, or terminating execution of at least one electronically implemented function of the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120) based on an analysis or evaluation of at least one of the distance and the relative position.
17. A computer program comprising computer readable instructions which, when executed by at least one processor (42, 62) of an electronic circuit (41, 61) according to any one of claims 1 to 9 or when executed by at least one processor (82, 102, 122) of a mobile electronic device (80, 100, 120) according to any one of claims 12 to 15, cause the processor (42, 62, 82, 102, 122) to: Establishing a wireless communication link between an electronic circuit (41, 61) attached to or integrated in the drug delivery device (1) and a mobile electronic device (80, 100, 120); determining at least one of a distance and a relative position between the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120) by transmission of wireless signals between the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120); analyzing or evaluating at least one of the distance and the relative position; The computer program causes at least one of enabling, disabling, triggering, or terminating the execution of at least one electronically implemented function of the electronic circuit (41, 61) and the mobile electronic device (80, 100, 120) based on an analysis or evaluation of at least one of the distance and the relative position.
Citation Information
Patent Citations
Electronic medical record system, electronic medical record browsing method, and program
JP2008203914A
Terminal device, information processing device and program
JP2016042630A
Operation terminal, operation terminal lock method and operation terminal lock system
JP2017118238A
drug delivery device
JP2018506401A
Drug delivery device with wireless connectivity and event detection
JP2020507841A
